OLMA
Olema Pharmaceuticals, Inc. · Healthcare
Director Cyrus Harmon sold $291K of Olema Pharmaceuticals, Inc.
Sold$291,163
$11.65Price
25,000Shares
−3%Stake
What OLMA did after the filing
- The stock from Tue, Jul 28 open, $11.86
- −9.9%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Sep 10 close.
Traded Thu, Jul 23. Filed Mon, Jul 27, 7:30 PM ET, after the close. Returns use the Jul 28 open and the Sep 10 close. Not investment advice.